Willcocks A L, Potter B V, Cooke A M, Nahorski S R
Department of Pharmacology and Therapeutics, University of Leicester, U.K.
Eur J Pharmacol. 1988 Oct 11;155(1-2):181-3. doi: 10.1016/0014-2999(88)90420-7.
D-Myo-inositol(1,4,5)trisphosphorothioate, a synthetic analogue of inositol(1,4,5)trisphosphate was shown to bind with a relatively high affinity to specific sites on rat cerebellar membranes labelled with [3H]inositol(1,4,5)trisphosphate. Use of this binding assay has also established that unlike the trisphosphate, the trisphosphorothioate is completely resistant to a specific 5-phosphatase prepared from human erythrocytes. The ability of this novel analogue to release intracellular Ca2+ has already been reported and it offers considerable potential in the investigation of phosphoinositide-linked receptors.